Insider · CIK 0001204391
Church Katrina J
Files at BVS (Bioventus Inc.). First filing Dec 26, 2024, latest Apr 15, 2025.
In brief
Church Katrina J files SEC Form 4 as officer at BVS (Bioventus Inc.). Since Dec 26, 2024, Church Katrina J has reported 0 open-market buys worth $0 and 4 open-market sells worth $62k, the latest filed on Apr 15, 2025.
A track record needs three past buys with six months of prices behind them; Church Katrina J has 0, so none is measured yet.
The newest scored trade: sold $9,712 of BVS on Apr 11, 2025, filed Apr 15, 2025, scored 10 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BVS: Bioventus Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Bioventus Inc. | $9,712 1,283 shares | -2% | 0% from low-45% from high | |
| 10Weak | Bioventus Inc. | $9,926 1,018 shares | -2% | - | |
| 10Weak | Bioventus Inc. | $16k 1,537 shares | -3% | - | |
| 15Weak | Bioventus Inc. | $27k 2,535 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 23, 2024 | BVS Bioventus Inc. | 8,000 0.01% of outstanding | $89k | Dec 23, 2024 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +4,300 | $0.00 | $0 | 66,032 | Apr 14, 2026 |
| Apr 10, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -1,868 | $9.06 | $17k | 64,164 | Apr 14, 2026 |
| Apr 10, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -4,300 | $0.00 | $0 | 4,300 | Apr 14, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +3,455 | $0.00 | $0 | 61,254 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -1,501 | $8.62 | $13k | 59,753 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +3,500 | $0.00 | $0 | 63,253 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -1,521 | $8.62 | $13k | 61,732 | Mar 17, 2026 |
| Mar 14, 2025 | BVS Bioventus Inc. | AGrant or award Restricted Stock Unitsderivative | +14,000 | $0.00 | $0 | 14,000 | Mar 17, 2026 |
| Mar 14, 2025 | BVS Bioventus Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | AGrant or award Restricted Stock Unitsderivative | +24,000 | $0.00 | $0 | 24,000 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | AGrant or award Stock Option (Right to Buy)derivative | +27,000 | $0.00 | $0 | 27,000 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -3,455 | $0.00 | $0 | 0 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -3,500 | $0.00 | $0 | 10,500 | Mar 17, 2026 |
| Feb 15, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +4,375 | $0.00 | $0 | 59,932 | Feb 18, 2026 |
| Feb 15, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -2,133 | $8.27 | $18k | 57,799 | Feb 18, 2026 |
| Feb 15, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -4,375 | $0.00 | $0 | 8,750 | Feb 18, 2026 |
| Apr 11, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,283 | $7.57 | $9,712 | 55,557 | Apr 15, 2025 |
| Apr 10, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +4,300 | $0.00 | $0 | 56,840 | Apr 11, 2025 |
| Apr 10, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -4,300 | $0.00 | $0 | 8,600 | Apr 11, 2025 |
| Mar 17, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,018 | $9.75 | $9,926 | 52,540 | Mar 18, 2025 |
| Mar 14, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +3,456 | $0.00 | $0 | 53,558 | Mar 14, 2025 |
| Mar 14, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -3,456 | $0.00 | $0 | 3,455 | Mar 14, 2025 |
| Feb 18, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,537 | $10.19 | $16k | 50,102 | Feb 20, 2025 |
| Feb 15, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +4,375 | $0.00 | $0 | 51,639 | Feb 18, 2025 |
| Feb 15, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -4,375 | $0.00 | $0 | 13,125 | Feb 18, 2025 |
| Dec 23, 2024 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -2,535 | $10.53 | $27k | 47,264 | Dec 26, 2024 |
| Dec 20, 2024 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +8,600 | $0.00 | $0 | 49,799 | Dec 23, 2024 |
| Dec 20, 2024 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -8,600 | $0.00 | $0 | 0 | Dec 23, 2024 |
Questions about Church Katrina J
Answered from the filings on this page, as of the latest one.
Is Church Katrina J buying or selling?
Not in the last 12 months. Church Katrina J's latest open-market trade on SEC Form 4 was sold $9,712 of BVS on Apr 11, 2025.
How did Church Katrina J's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Church Katrina J has 0.
Where does Church Katrina J file Form 4?
Church Katrina J has filed Form 4 at BVS (Bioventus Inc.) as SVP & Chief Compliance Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.